Condition

Glycogen Storage Disease Type 2 (3)

Acid Maltase Deficiency (2)

LOPD (2)

Lysosomal Storage Diseases (2)

Pompe Disease (2)

Pompe Disease (Late-onset) (2)

Dystrophia Myotonica (1)

Glycogen Storage Disease Type II (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Unknown status (1)

Sign in for free

Phase

n/a (1)

phase 1/phase 2 (1)

Sponsor

Spark Therapeutics (2)

University of Aarhus (1)

Collaborator

Intervention

neutralizing antibody to spk-3006 capsid (1)

spk-3006 (1)

Study Documents

Intervention Type

diagnostic test (1)

genetic (1)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (2)

Observational (1)

glycogen storage disease type 2

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Pompe Disease, Pompe Disease (Late-onset), Glycogen Storage Disease Type 2 Trial in Worldwide (SPK-3006)

Active, not recruiting

Pompe Disease
+6 more

SPK-3006

Phoenix, Arizona
+28 more

Jul 22, 2022

Pompe Disease, Pompe Disease (Late-onset), Glycogen Storage Disease Type 2 Trial in Worldwide (Neutralizing Antibody to SPK-3006

Completed

Pompe Disease
+5 more

Neutralizing Antibody to SPK-3006 capsid

Phoenix, Arizona
+17 more

Jul 14, 2021

Muscular Diseases -Pompe Disease and Dystrophia Myotonica-

Unknown status

Glycogen Storage Disease Type 2
Dystrophia Myotonica

Aarhus C, Denmark
+1 more

Mar 9, 2016